US EditionHealth Suspects that Novo Nordisk's New Campaign Against Obesity Is "Indirect Advertising"
5 Articles
5 Articles
An advertising campaign called “Obesity without filters”, launched by pharmaceutical company Novo Nordisk, manufacturer of the well-known drug Ozempic, has generated...
The Ministry has sent a request for information to the manufacturer of the well-known Ozempic to analyze whether it is violating the advertising rules for prescription drugs with an initiative that is endorsed by several scientific societies.
The Ministry of Health considers that the pharmaceutical company Novo Nordisk has been able to violate the law prohibiting the advertising of medicines on its website dedicated to overweight and obesity, and has therefore required it to provide all the documentation that proves the support of scientific and professional organizations, EFE gathers. The Directorate-General for the Common Portfolio of Services of the National Health and Pharmacy Sy…
According to this ministry, although Novo Nordisk does not explicitly mention any pharmacological treatment, the whole content could constitute a form of indirect advertising of medicinal products subject to medical prescription.Topics: News, GordophobiaRead full article
Semaglutide drugs are under the spotlight. Ozempic, Wegovy, Rybelsus and Mounjaro are some of the drugs that are ‘under observation’ because of the side effects they cause on patients. One of the most recent, of which the pharmaceutical industry in England has already warned, is the increase in pregnancies in women who inject semaglutide drugs to lose weight. Novo Nordisk, a manufacturer of several of these drugs, questioned by this newspaper, h…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
